Sam Watson
Chief Executive Officer at BIOXYNE LIMITED
Profile
Sam Watson is the founder and Chief Executive Officer of Breathe International Ltd., a position he has held since 2018.
He is also the founder of Breathe Life Sciences UK Ltd.
Currently, Mr. Watson is the Chief Executive Officer, MD & Executive Director of Bioxyne Ltd., the Chief Executive Officer of Breathe Life Sciences Pty Ltd., and the Director of Doctime Ltd.
Mr. Watson completed his undergraduate degree at The Leonard N Stern School of Business.
Sam Watson active positions
Companies | Position | Start |
---|---|---|
BIOXYNE LIMITED | Chief Executive Officer | 18/05/2023 |
Breathe Life Sciences Pty Ltd.
Breathe Life Sciences Pty Ltd. Pharmaceuticals: OtherHealth Technology Part of Bioxyne Ltd., Breathe Life Sciences Pty Ltd. is an Australian company that manufactures plant-based wellness products. The company is based in Daisy Hill, Australia. The company was founded in 2019. The CEO is Sam Watson. Breathe Life Sciences was acquired by Bioxyne Ltd. on May 22, 2023 for $20.54 million. | Chief Executive Officer | - |
Breathe Life Sciences UK Ltd.
Breathe Life Sciences UK Ltd. Agricultural Commodities/MillingProcess Industries Part of Bioxyne Ltd., Breathe Life Sciences UK Ltd. is a company that manufactures and sells plant and mushroom based wellness products and health supplements. The company is based in London, UK. The British company was founded in 2022 by Sam Watson. Sam Watson has been the CEO since 2022. | Founder | - |
Doctime Ltd.
Doctime Ltd. Packaged SoftwareTechnology Services Doctime Ltd. provides telemedicine services to ensure proper healthcare and well-being for the masses. The private company is located in the UK. Since 2018, the British company has been offering online medicine orders with a 5% discount for those who upload their prescription. The company guarantees safe and timely delivery to your doorstep. The company also offers specialized doctors in various categories for online video consultation appointments. The company's goal is to improve health and well-being with advanced technology from the best doctors and highest-rated patient experiences. | Director/Board Member | 30/09/2020 |
Training of Sam Watson
The Leonard N Stern School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOXYNE LIMITED | Commercial Services |
Private companies | 3 |
---|---|
Breathe Life Sciences Pty Ltd.
Breathe Life Sciences Pty Ltd. Pharmaceuticals: OtherHealth Technology Part of Bioxyne Ltd., Breathe Life Sciences Pty Ltd. is an Australian company that manufactures plant-based wellness products. The company is based in Daisy Hill, Australia. The company was founded in 2019. The CEO is Sam Watson. Breathe Life Sciences was acquired by Bioxyne Ltd. on May 22, 2023 for $20.54 million. | Health Technology |
Breathe Life Sciences UK Ltd.
Breathe Life Sciences UK Ltd. Agricultural Commodities/MillingProcess Industries Part of Bioxyne Ltd., Breathe Life Sciences UK Ltd. is a company that manufactures and sells plant and mushroom based wellness products and health supplements. The company is based in London, UK. The British company was founded in 2022 by Sam Watson. Sam Watson has been the CEO since 2022. | Process Industries |
Doctime Ltd.
Doctime Ltd. Packaged SoftwareTechnology Services Doctime Ltd. provides telemedicine services to ensure proper healthcare and well-being for the masses. The private company is located in the UK. Since 2018, the British company has been offering online medicine orders with a 5% discount for those who upload their prescription. The company guarantees safe and timely delivery to your doorstep. The company also offers specialized doctors in various categories for online video consultation appointments. The company's goal is to improve health and well-being with advanced technology from the best doctors and highest-rated patient experiences. | Technology Services |
- Stock Market
- Insiders
- Sam Watson